C.R. Franks
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 27
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 8
- Cancer Cells and Metastasis 4
- Immunology 23
- Immunotherapy and Immune Responses 14
- Immune Cell Function and Interaction 12
- Co-authors
- F. T. Perkins (7 shared papers)Peter Palmer (12 shared papers)G. Stoter (4 shared papers)Oleg Eremin (4 shared papers)R. L. H. Bolhuis (1 shared paper)R. Oskam (3 shared papers)S.H. Goey (1 shared paper)Rob L. H. Jansen (1 shared paper)
- Journals
- Cancer Treatment Reviews (9 papers)British Journal of Cancer (7 papers)European Journal of Cancer (3 papers)Cancer Immunology Immunotherapy (2 papers)Journal of Immunotherapy (2 papers)
- Partner nations
- United KingdomFranceCanada
In The Last Decade
C.R. Franks
51 papers receiving 626 citations
Peers
Comparison fields: 5 of 76
- Immunology 277
- Oncology 276
- Hematology 86
- Biotechnology 40
- Neurology 49
Countries citing papers authored by C.R. Franks
This map shows the geographic impact of C.R. Franks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.R. Franks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.R. Franks more than expected).
Fields of papers citing papers by C.R. Franks
This network shows the impact of papers produced by C.R. Franks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.R. Franks. The network helps show where C.R. Franks may publish in the future.
Co-authors
The 25 scholars most cited alongside C.R. Franks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 48 | |
| 2 | 2014 | 46 | |
| 3 | 1991 | 37 | |
| 4 | Optimal conditions for the growth of malignant human and animal cell populations in immunosuppressed mice. | 1975 | 31 |
| 5 | 1990 | 29 | |
| 6 | 1975 | 26 | |
| 7 | 1994 | 23 | |
| 8 | 1989 | 22 | |
| 9 | 1991 | 20 | |
| 10 | 1990 | 19 | |
| 11 | 1977 | 19 | |
| 12 | 1989 | 18 | |
| 13 | 1989 | 18 | |
| 14 | 1986 | 18 | |
| 15 | 1993 | 17 | |
| 16 | 1994 | 17 | |
| 17 | 1989 | 16 | |
| 18 | 1976 | 15 | |
| 19 | 1988 | 15 | |
| 20 | 1990 | 15 |
About C.R. Franks
C.R. Franks is a scholar working on Oncology, Immunology, Molecular Biology, Hematology and Biotechnology, having authored 51 papers that have together received 674 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (8 papers), Cancer Research and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (4 papers), Neuroblastoma Research and Treatments (4 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Immunology (277 citations), Oncology (276 citations), Hematology (86 citations), Biotechnology (40 citations) and Neurology (49 citations). C.R. Franks has collaborated with scholars based in United Kingdom, France and Canada. Frequent co-authors include F. T. Perkins, Peter Palmer, G. Stoter, Oleg Eremin, R. L. H. Bolhuis, R. Oskam, S.H. Goey, Rob L. H. Jansen, Yvonne Williams and Aiping Liu. Their work appears in journals such as Cancer Treatment Reviews, British Journal of Cancer, European Journal of Cancer, Cancer Immunology Immunotherapy and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.